© Reuters. FILE PHOTO: Dave Lewis, Tesco CEO, speaks at the the British Chamber of Commerce annual conference in London, Britain, March 28, 2019. REUTERS/Peter Nicholls
(Reuters) – GlaxoSmithKline (NYSE:) Plc has picked former Chief Executive Officer of Tesco (OTC:) Plc Dave Lewis to head GSK’s consumer healthcare unit, which is being spun off into a standalone business, Sky News reported on Sunday.
Confirmation of his appointment could come as soon as Monday, the broadcaster said.
GSK did not immediately respond to a Reuters request for comment.
The 40 billion pound ($53 billion) spinoff is due to take effect next year.
($1 = 0.7551 pounds)
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment